Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease

Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 and March 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Satohiro, Mashima, Hirosato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747557/
https://www.ncbi.nlm.nih.gov/pubmed/33335169
http://dx.doi.org/10.1038/s41598-020-79207-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747557/
https://www.ncbi.nlm.nih.gov/pubmed/33335169
http://dx.doi.org/10.1038/s41598-020-79207-z

Ejemplares similares